David Fyfield writes for Intellectual Property Magazine on the impact of Warner-Lambert v Actavis judgment
David Fyfield has written an article for Intellectual Property Magazine on the impact of Warner-Lambert v Actavis judgment for second-medical use patents. Read more below (subscription required).
Warner-Lambert Company LLC v Generics (UK) Ltd/t/a Mylan & Anor